NTRP NextTrip, Inc.
Price Chart
Executive Summary
The SEC declared effective NextTrip's S-3 registration statement (File No. 333-296201) on June 3, 2026, enabling the resale of up to 537,894 shares of common stock by selling stockholders. These shares are issuable upon conversion of Series B Preferred Stock and exercise of warrants from a May 2026 private placement. This adds to an existing overhang from a prior S-3 covering 2,000,000 shares, creating significant potential dilution for a $33M market cap company with nominal revenues and a going concern qualification.
Actionable Insight
The effectiveness of this shelf, combined with the prior 2M-share shelf, creates a heavy overhang for NTRP. Monitor for any takedown announcements or accelerated selling by the selling stockholders. The August 30, 2026 Series B Preferred redemption deadline adds financial strain — any default could trigger additional dilution via cashless warrant exercises. Traders should watch for volume spikes and price weakness near that date.
Key Facts
- Effectiveness date: June 3, 2026 for S-3 File No. 333-296201.
- Registration covers 537,894 shares for resale by selling stockholders.
- Shares are issuable upon conversion of Series B Preferred Stock and exercise of warrants from a May 2026 private placement.
- Company has nominal revenues and a going concern qualification per prior S-3/A filing.
- Series B Preferred must be redeemed by August 30, 2026 or risk default triggering cashless warrant exercises.
- A prior S-3 (filed Jan 2, 2026) covering 2,000,000 shares remains effective, adding to total potential dilution.
- Market cap is approximately $33M; combined potential dilution from both shelves is substantial relative to current float.
Financial Impact
Up to 537,894 new shares can be sold into the market, adding to an existing 2,000,000-share overhang from a prior shelf. For a $33M market cap company, this represents material potential dilution.
Risk Factors
- Significant dilution risk from up to 2.54M shares registered across two effective shelves relative to a ~$33M market cap.
- Going concern qualification and nominal revenues increase the likelihood of distressed equity issuance.
- Series B Preferred redemption deadline on August 30, 2026 could force additional dilutive financing if cash is insufficient.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001873 |
| Document: 9999999995-26-001873-index.html | 9999999995-26-001873 |
| Document: 9999999995-26-001873.txt | 9999999995-26-001873 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
1d ago
|
8-K
| — | awaiting T+5 | — | — |
|
Jun 4, 2026
1d ago
|
EFFECT
| — | awaiting T+5 | — | — |
|
May 30, 2026
6d ago
|
S-3/A
| — | awaiting T+5 | — | — |
|
May 22, 2026
14d ago
|
S-3
| $2.29 $2.37 | ▼ −3.53% | ▼ −2.32% | $2.46 (−7.42%) |
|
May 8, 2026
28d ago
|
8-K
| $2.48 $2.41 | ▲ +2.82% | ▲ +2.74% | $2.46 (+0.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access